Viracta TherapeuticsVIRX
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 40 institutions reported holding Viracta Therapeutics Inc. (VIRX) in their 13F filings, unchanged from Q1 2024. 2 opened new positions and 2 sold out. The largest holders were BVF Inc. ($2.0M), Citadel Advisors ($827K) and Vanguard Group Inc. ($631K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Viracta Therapeutics Inc.
- CUSIP
- 92765F108
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $17K |
| Exits | 2 | $27K |
All 13F filers, Q1 2024 → Q2 2024: 90,841 shares bought and 458,268 shares sold, net −367,427 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 40 holders
| BVF Inc. | 0.06% | No change | 3,614,662 | $2.0M |
| Citadel Advisors | 0.00% | Reduce -2.9% | 1,520,240 | $827K |
| Vanguard Group Inc. | 0.00% | No change | 1,161,280 | $631K |
| Samsara Biocapital, LLC | 0.08% | No change | 689,709 | $375K |
| Laurion Capital Management LP | 0.01% | Reduce -3.1% | 407,299 | $221K |
| Aisling Capital Management LP | 0.07% | No change | 288,571 | $157K |
| BlackRock Inc. | 0.00% | Reduce -10.1% | 273,297 | $149K |
| Geode Capital Management, LLC | 0.00% | Add +7.2% | 270,773 | $147K |
| Renaissance Technologies | 0.00% | Add +7.5% | 217,699 | $118K |
| Morgan Stanley | 0.00% | Add +14.0% | 134,544 | $73K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 74,000 | $40K |
| State Street Corp. | 0.00% | No change | 65,867 | $36K |
| Ensign Peak Advisors, Inc | 0.00% | Reduce -2.9% | 61,601 | $33K |
| Northern Trust Corp. | 0.00% | Reduce -0.2% | 38,104 | $21K |
| Virtu Financial LLC | 0.00% | New | 30,789 | $17K |
| MAI Capital Management | 0.00% | Reduce -92.5% | 27,417 | $15K |
| XTX Topco Ltd | 0.00% | Add +13.0% | 19,201 | $10K |
| Inspirion Wealth Advisors, LLC | 0.00% | No change | 15,000 | $8K |
| Beacon Pointe Advisors, LLC | 0.00% | Reduce -14.3% | 15,000 | $8K |
| Hoylecohen, LLC | 0.00% | No change | 14,000 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +42.3% | 12,652 | $7K |
| Bank of America Corp. | 0.00% | Add +1.8% | 12,496 | $7K |
| Trust Co. of Toledo NA | 0.00% | No change | 12,317 | $7K |
| WealthTrust Axiom LLC | 0.00% | No change | 11,396 | $6K |
| Acadian Asset Management LLC | 0.00% | No change | 10,908 | $5K |
| Planning Capital Management Corp | 0.00% | No change | 7,272 | $4K |
| Simplex Trading, LLC | 0.00% | Add +50.2% | 7,337 | $3K |
| RP Management, LLC | 0.00% | No change | 3,700 | $2K |
| IAG Wealth Partners, LLC | 0.00% | No change | 3,000 | $2K |
| Barclays PLC | 0.00% | No change | 2,668 | $1K |
| UBS Group AG | 0.00% | Add +1679.0% | 1,690 | $920 |
| JPMorgan Chase & Co. | 0.00% | No change | 721 | $392 |
| Indiana Trust & Investment Management Co | 0.00% | No change | 200 | $109 |
| Wells Fargo & Company | 0.00% | Reduce -55.6% | 171 | $93 |
| NewEdge Advisors, LLC | 0.00% | No change | 14 | $8 |
| Parallel Advisors, LLC | 0.00% | No change | 8 | $4 |
| Addison Advisors LLC | 0.00% | No change | 4 | $3 |
| Private Ocean, LLC | 0.00% | New | 3 | $2 |
| Qube Research & Technologies Ltd | 0.00% | No change | 2 | $1 |
| Royal Bank of Canada | 0.00% | Reduce -77.9% | 457 | $0 |
"% of holder's portfolio" is VIRX's weight in each manager's 13F, not the share of Viracta Therapeutics Inc. the manager owns.